Exabis Library
Welcome to the e-CCO Library!
P789: Incidence and survival of gastrointestinal cancer in patients with inflammatory bowel disease: A nationwide population-based study in Korea
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P789: Inflammatory Bowel Disease subgroups identified by longitudinal faecal calprotectin profiles: A 10-year retrospective analysis of the Lothian IBD Registry
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P789: Microbiome composition is altered in patients with IBD independent of endoscopic activity
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P789: Symptom burden and lack of remission among adult patients with ulcerative colitis (UC): retrospective analysis of cross-sectional survey data from the US and Germany
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P790 Dental caries occurrence among patients with inflammatory bowel disease (IBD)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P790: Assessing the cost-effectiveness of Epstein–Barr virus screening in young men initiating combination therapy with infliximab and azathioprine for Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P790: Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P790: Examining mental health disease burden among Crohn's Disease (CD) patients in Europe
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P790: Microbiota profile in pediatric IBD: correlations with phenotype and disease activity
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P791 Difference between paediatric Crohn’s disease and ulcerative colitis at diagnosis in Korea: results from a multicentre, registry-based, retrospective cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P791: Activation of the aryl hydrocarbon receptor after simvastatin and recombinant antagonist of receptors of interleukin-1 treatment in a rat model of inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P791: Influence of patients’ preference in randomised controlled trials
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P791: Peripheral spondyloarthritis, peripheral arthritis, and IBD-related peripheral arthritis in patients with long-term IBD: Results from 20 years of follow-up in the IBSEN study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P791: Up to one third of rapid thiopurine-S-methyltransferase metabolizers manifest clinical and/or laboratory azathioprine side effects: A single centre experience
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P792 Breastfeeding in our patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P792: Modulation of the fecal metagenome in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P792: Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P792: Phenotype and natural history of inflammatory bowel disease: results from the largest centre in Singapore
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P792: Prevalence of inflammatory bowel diseases in Israeli Jewish and Druze adolescents, a longitudinal comparative study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P793 Patients’ concerns are strongly associated with distress and quality of life among family caregivers of adult inflammatory bowel disease patients in remission
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM